ImmunityBio (IBRX) Fair Value & DCF
IBRX$6.22+0.24 +4.10%
Market cap$6.62BEnterprise value$10.20BRevenue (TTM)$165.79MMarket position—
Score
65
Bullish
Value
63
Quality
33
Growth
100
ImmunityBio, Inc. (IBRX) trades at $6.22 on $6.62B of equity value, with a trailing P/E of -9.17. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.